New Software for MR Breast Imaging Simplifies Diagnoses and Biopsies

Siemens HealthcareWith its new diagnostic reporting software for breast imaging in magnetic resonance imaging (MRI), Siemens Healthcare provides radiologists with new opportunities in Women's Health. The syngo BreVis diagnostic reporting software shows all of a patient's examination results in a single view - for example ultrasound or radiography images next to the images from magnetic resonance imaging - impossible with previous technology. Additionally, the physician can use the new syngo BreVis Biopsy interventional software to plan and perform a biopsy when needed. It is almost fully automated and much faster than before. As such, this fast and efficient application represents a major advance for patients and users.

Given its high number of images, MR breast imaging is particularly challenging to diagnostic reporting software. Siemens faced this challenge with ongoing development and the implementation of new ideas. Its latest innovations in the area of MR breast imaging include the Magnetom Espree - Pink breast scanner, as well as a comprehensive range of applications specifically for MR breast imaging. These have now been enhanced by specialized syngo BreVis and syngo BreVis Biopsy software solutions. Syngo workplaces support both of these new solutions, which are computer-based diagnostic tools.

The syngo Brevis Workplace is a flexible hardware and software solution that is easy to use while simultaneously providing efficient diagnostic reporting. To establish a diagnosis, the physician can display ultrasound or radiography images in addition to magnetic resonance images, compare them, and process them individually, all on a single screen. The syngo Brevis Workplace enables almost fully automated reporting, elastic image correction of data should the patient move, color display of dynamic image information, and calculation of lesion volume. Diagnostic workflows are further optimized because the syngo Brevis diagnostic report is based on the BI-RADS classification. This Breast Imaging Reporting and Data System (BI-RADS) is a classification of breast lesions for diagnostic reporting accepted worldwide, and was created by the American College of Radiology (ACR).

The syngo Brevis Biopsy Workplace offers the physician an intuitive, fast, and precise means for planning and performing biopsies. The software automatically calculates the coordinates of the breast tissue to be removed. All components work together so that the intervention can be performed easier and faster than before, an advantage both to the patient and examining physician.

The new software solutions were developed by MeVis in close cooperation with Siemens. They are part of the Magnetom Espree - Pink dedicated MR breast scanner, but are also available for all other systems of the Magnetom family from Siemens. "In addition to the well-known high diagnostic reliability of our software applications, this specialized MRI solution is characterized by an unusually high clinical process efficiency," said Dr. Carl J.G. Evertsz, CEO of MeVis Medical Solutions AG. "The new syngo BreVis diagnostic reporting software represents a major step toward real multi-modality diagnostics."

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...